Topical and intralesional therapies for alopecia areata

Dermatol Ther. 2011 May-Jun;24(3):355-63. doi: 10.1111/j.1529-8019.2011.01419.x.

Abstract

Alopecia areata is a common form of nonscarring alopecia. It affects males and females equally and has no racial predilection. It usually affects the scalp, but any hair-bearing area can be involved. It presents as patchy hair loss, loss of hair on the entire scalp (alopecia totalis), or the whole body (alopecia universalis). The histopathology varies according to the disease stage, but usually a perifollicular lymphocytic infiltrate is seen. The course of the disease and response to treatment are unpredictable. Various therapeutic modalities are used including topical, intralesional, and systemic agents, although none are curative or preventive. This article will review the available topical and intralesional agents that are used in the treatment of alopecia areata and suggest a management approach based on the age of the patient and extent of the disease.

Publication types

  • Review

MeSH terms

  • Administration, Topical
  • Age Factors
  • Alopecia / drug therapy*
  • Alopecia / pathology
  • Alopecia / therapy
  • Alopecia Areata / drug therapy*
  • Alopecia Areata / pathology
  • Alopecia Areata / therapy
  • Animals
  • Female
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use*
  • Hair Follicle / pathology
  • Humans
  • Injections, Intralesional
  • Lymphocytes / metabolism
  • Male
  • Phototherapy / methods
  • Severity of Illness Index

Substances

  • Glucocorticoids

Supplementary concepts

  • Alopecia universalis